130 related articles for article (PubMed ID: 36266255)
1. Impact of the SARS-CoV-2 pandemic on the health of individuals with intoxication-type metabolic diseases-Data from the E-IMD consortium.
Mütze U; Gleich F; Barić I; Baumgartner M; Burlina A; Chapman KA; Chien YH; Cortès-Saladelafont E; De Laet C; Dobbelaere D; Eysken F; Gautschi M; Santer R; Häberle J; Joaquín C; Karall D; Lindner M; Lund AM; Mühlhausen C; Murphy E; Roland D; Ruiz Gomez A; Skouma A; Grünert SC; Wagenmakers M; Garbade SF; Kölker S; Boy N
J Inherit Metab Dis; 2023 Mar; 46(2):220-231. PubMed ID: 36266255
[TBL] [Abstract][Full Text] [Related]
2. One year of COVID-19: infection rates and symptoms in patients with inherited metabolic diseases followed by MetabERN.
Paneghetti L; Bellettato CM; Sechi A; Stepien KM; Scarpa M
Orphanet J Rare Dis; 2022 Mar; 17(1):109. PubMed ID: 35246188
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 in Unvaccinated patients with inherited metabolic disorders: A single center experience.
Altassan R; Sulaiman RA; Alfalah A; Alwagiat W; Megdad E; Alqasabi D; Handoom B; Almesned M; Al-Amri H; Alhassnan Z; Alsayed MA; Alzaidan H; Rahbeeni Z; Derar N; Al-Owain M; Albanyan E
Eur J Med Genet; 2022 Nov; 65(11):104602. PubMed ID: 36049607
[TBL] [Abstract][Full Text] [Related]
4. SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study.
Luchetti Gentiloni MM; Paci V; Marconi V; Gigli M; Benfaremo D; Sordillo R; Macchini C; Massaccesi L; Perna GP; Offidani AM; Moroncini G
Front Immunol; 2022; 13():859550. PubMed ID: 35386714
[TBL] [Abstract][Full Text] [Related]
5. The impact of COVID-19 on rare metabolic patients and healthcare providers: results from two MetabERN surveys.
Lampe C; Dionisi-Vici C; Bellettato CM; Paneghetti L; van Lingen C; Bond S; Brown C; Finglas A; Francisco R; Sestini S; Heard JM; Scarpa M;
Orphanet J Rare Dis; 2020 Dec; 15(1):341. PubMed ID: 33272301
[TBL] [Abstract][Full Text] [Related]
6. Behavioural and emotional problems, intellectual impairment and health-related quality of life in patients with organic acidurias and urea cycle disorders.
Jamiolkowski D; Kölker S; Glahn EM; Barić I; Zeman J; Baumgartner MR; Mühlhausen C; Garcia-Cazorla A; Gleich F; Haege G; Burgard P;
J Inherit Metab Dis; 2016 Mar; 39(2):231-41. PubMed ID: 26310964
[TBL] [Abstract][Full Text] [Related]
7. Decreased plasma l-arginine levels in organic acidurias (MMA and PA) and decreased plasma branched-chain amino acid levels in urea cycle disorders as a potential cause of growth retardation: Options for treatment.
Molema F; Gleich F; Burgard P; van der Ploeg AT; Summar ML; Chapman KA; Lund AM; Rizopoulos D; Kölker S; Williams M;
Mol Genet Metab; 2019 Apr; 126(4):397-405. PubMed ID: 30827756
[TBL] [Abstract][Full Text] [Related]
8. Networking Across Borders for Individuals with Organic Acidurias and Urea Cycle Disorders: The E-IMD Consortium.
Kölker S; Dobbelaere D; Häberle J; Burgard P; Gleich F; Summar ML; Hannigan S; Parker S; Chakrapani A; Baumgartner MR;
JIMD Rep; 2015; 22():29-38. PubMed ID: 25701269
[TBL] [Abstract][Full Text] [Related]
9. Symptoms of SARS-CoV-2 infection and vaccine status of sixty-seven adult patients affected by inherited metabolic diseases: a phone survey.
Brodosi L; Stecchi M; Mita D; Marchignoli F; Guarneri V; Agnelli G; Osti V; Perazza F; Sacilotto F; Pession A; Pironi L
Orphanet J Rare Dis; 2023 Sep; 18(1):286. PubMed ID: 37700355
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of dietary treatment and amino acid supplementation in organic acidurias and urea-cycle disorders: On the basis of information from a European multicenter registry.
Molema F; Gleich F; Burgard P; van der Ploeg AT; Summar ML; Chapman KA; Barić I; Lund AM; Kölker S; Williams M;
J Inherit Metab Dis; 2019 Nov; 42(6):1162-1175. PubMed ID: 30734935
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 in inherited metabolic disorders: Clinical features and risk factors for disease severity.
Kahraman AB; Yıldız Y; Çıkı K; Erdal I; Akar HT; Dursun A; Tokatlı A; Sivri S
Mol Genet Metab; 2023 Jun; 139(2):107607. PubMed ID: 37201420
[TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
13. Challenges of following patients with inherited metabolic diseases during the COVID-19 outbreak. A cross-sectional online survey study.
Oge Enver E; Hopurcuoglu D; Ahmadzada S; Zubarioglu T; Aktuglu Zeybek AC; Kiykim E
J Pediatr Endocrinol Metab; 2021 Jan; 34(1):103-107. PubMed ID: 33185576
[TBL] [Abstract][Full Text] [Related]
14. On the Creation, Utility and Sustaining of Rare Diseases Research Networks: Lessons learned from the Urea Cycle Disorders Consortium, the Japanese Urea Cycle Disorders Consortium and the European Registry and Network for Intoxication Type Metabolic Diseases.
Summar ML; Endo F; Kölker S
Mol Genet Metab; 2014; 113(1-2):105-8. PubMed ID: 25261246
[TBL] [Abstract][Full Text] [Related]
15. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic.
Balachandren N; Davies MC; Hall JA; Stephenson JM; David AL; Barrett G; O'Neill HC; Ploubidis GB; Yasmin E; Mavrelos D
Hum Reprod; 2022 May; 37(6):1126-1133. PubMed ID: 35389480
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial.
Herman GA; O'Brien MP; Forleo-Neto E; Sarkar N; Isa F; Hou P; Chan KC; Bar KJ; Barnabas RV; Barouch DH; Cohen MS; Hurt CB; Burwen DR; Marovich MA; Musser BJ; Davis JD; Turner KC; Mahmood A; Hooper AT; Hamilton JD; Parrino J; Subramaniam D; Baum A; Kyratsous CA; DiCioccio AT; Stahl N; Braunstein N; Yancopoulos GD; Weinreich DM;
Lancet Infect Dis; 2022 Oct; 22(10):1444-1454. PubMed ID: 35803290
[TBL] [Abstract][Full Text] [Related]
18. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation.
Kölker S; Garcia-Cazorla A; Valayannopoulos V; Lund AM; Burlina AB; Sykut-Cegielska J; Wijburg FA; Teles EL; Zeman J; Dionisi-Vici C; Barić I; Karall D; Augoustides-Savvopoulou P; Aksglaede L; Arnoux JB; Avram P; Baumgartner MR; Blasco-Alonso J; Chabrol B; Chakrapani A; Chapman K; I Saladelafont EC; Couce ML; de Meirleir L; Dobbelaere D; Dvorakova V; Furlan F; Gleich F; Gradowska W; Grünewald S; Jalan A; Häberle J; Haege G; Lachmann R; Laemmle A; Langereis E; de Lonlay P; Martinelli D; Matsumoto S; Mühlhausen C; de Baulny HO; Ortez C; Peña-Quintana L; Ramadža DP; Rodrigues E; Scholl-Bürgi S; Sokal E; Staufner C; Summar ML; Thompson N; Vara R; Pinera IV; Walter JH; Williams M; Burgard P
J Inherit Metab Dis; 2015 Nov; 38(6):1041-57. PubMed ID: 25875215
[TBL] [Abstract][Full Text] [Related]
19. U-IMD: the first Unified European registry for inherited metabolic diseases.
Opladen T; Gleich F; Kozich V; Scarpa M; Martinelli D; Schaefer F; Jeltsch K; Juliá-Palacios N; García-Cazorla Á; Dionisi-Vici C; Kölker S
Orphanet J Rare Dis; 2021 Feb; 16(1):95. PubMed ID: 33602304
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 Pandemic and Patients with Rare Inherited Metabolic Disorders and Rare Autoinflammatory Diseases-Organizational Challenges from the Point of View of Healthcare Providers.
Tobór-Świętek E; Sykut-Cegielska J; Bik-Multanowski M; Walczak M; Rokicki D; Kałużny Ł; Wierzba J; Pac M; Jahnz-Różyk K; Więsik-Szewczyk E; Kieć-Wilk B
J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
